Progyny, Inc. (PGNY)

33.39 -0.42 (-1.24%) At close: 04:00PM EDT

Progyny, Inc.

1359 Broadway
New York, NY 10018
United States
212 888 3124
https://www.progyny.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 563

Key executives

Name	Title	Pay	Exercised	Year born
Mr. David J. Schlanger	Executive Chairman	510.41k	42.22M	1959
Mr. Peter Anevski	CEO & Director	1.01M	11.97M	1967
Mr. Michael Sturmer	President	761.5k	N/A	1977
Mr. Mark S. Livingston	Chief Financial Officer	693.87k	N/A	1966
Mr. Steven Leist	Chief Technology Officer	N/A	N/A	N/A
Mr. James Hart	Vice President of Investor Relations	N/A	N/A	N/A
Ms. Risa Fisher	Chief Marketing Officer	N/A	N/A	N/A
Ms. Cassandra Pratt	Chief Human Resources Officer	N/A	N/A	N/A
Ms. Julie Stadlbauer	Chief Business Development Officer	N/A	N/A	N/A
Ms. Janet Choi M.D.	Member of the Medical Advisory Board & Chief Medical Officer	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Corporate governance

Progyny, Inc.’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 1; Board: 8; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.